Hui Wang focuses on Cancer research, Cancer, Pharmacology, In vivo and Internal medicine. His research in Cancer research intersects with topics in Cell growth, Cell cycle, Oncogene, Mdm2 and Metastasis. His work in Cancer covers topics such as Oligonucleotide which are related to areas like Molecular biology and CpG site.
His Pharmacology research is multidisciplinary, incorporating perspectives in Carboplatin, Chemosensitizer, Cytotoxicity, Biochemistry and Gemcitabine. Hui Wang studied In vivo and Apoptosis that intersect with Cell culture and Lung cancer. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Surgery and Oncology.
His scientific interests lie mostly in Internal medicine, Cancer research, Cell biology, Cancer and Immunology. His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Oncology. His research integrates issues of Cell growth, Downregulation and upregulation, Oncogene, Metastasis and In vivo in his study of Cancer research.
His In vivo study integrates concerns from other disciplines, such as In vitro and Pharmacology.
The scientist’s investigation covers issues in Cancer research, Internal medicine, Catalysis, Chemical engineering and Cell biology. His Cancer research research integrates issues from Downregulation and upregulation, Metastasis and In vivo. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His research in Gastroenterology is mostly focused on Cirrhosis. He does research in Catalysis, focusing on Selectivity specifically.
Hui Wang mainly investigates Cancer research, Induced pluripotent stem cell, Organoid, Metastasis and Internal medicine. His Cancer research study focuses on Hepatocellular carcinoma in particular. The study incorporates disciplines such as Cell culture, Immunology, Chemokine and Fetus, Amnion in addition to Induced pluripotent stem cell.
His Organoid research includes themes of Nanotechnology, Insulin secretion, Virus, Stem cell and Droplet microfluidics. His study explores the link between Metastasis and topics such as Immune system that cross with problems in Autocrine signalling, Paracrine signalling, Microvesicles, Reprogramming and Primary liver cancer. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Bioavailability and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation
Jiechao Ge;Minhuan Lan;Bingjiang Zhou;Weimin Liu.
Nature Communications (2014)
Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Hue H. Luu;Ruiwen Zhang;Rex C. Haydon;Elizabeth Rayburn.
Current Cancer Drug Targets (2004)
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
Shi You Li;Cong Chen;Hai Qing Zhang;Hai Yan Guo.
Antiviral Research (2005)
Meta-analysis of vitamin D, calcium and the prevention of breast cancer.
Peizhan Chen;Pingting Hu;Dong Xie;Ying Qin.
Breast Cancer Research and Treatment (2010)
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
Junmei Hou;Disong Wang;Ruiwen Zhang;Hui Wang.
Clinical Cancer Research (2008)
In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
Wei Wang;Yuqing Zhao;Yuqing Zhao;Elizabeth R. Rayburn;Donald L. Hill.
Cancer Chemotherapy and Pharmacology (2007)
Quadruple H-Bonding Cross-Linked Supramolecular Polymeric Materials as Substrates for Stretchable, Antitearing, and Self-Healable Thin Film Electrodes
Xuzhou Yan;Zhiyuan Liu;Qiuhong Zhang;Qiuhong Zhang;Jeffrey Lopez.
Journal of the American Chemical Society (2018)
MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy
Elizabeth Rayburn;Ruiwen Zhang;Jie He;Hui Wang.
Current Cancer Drug Targets (2005)
MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53
Zhuo Zhang;Hui Wang;Mao Li;Sudhir Agrawal.
Journal of Biological Chemistry (2004)
Mixing ionic liquids – “simple mixtures” or “double salts”?
Gregory Chatel;Jorge F. B. Pereira;Varun Debbeti;Hui Wang.
Green Chemistry (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: